PML/RARα-regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in acute promyelocytic leukemia

Daniela Bräuer-Hartmann, Jens Uwe Hartmann, Alexander Arthur Wurm, Dennis Gerloff, Christiane Katzerke, Maria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Carsten Müller-Tidow, Daniel G. Tenen, Dietger Niederwieser, Gerhard Behre

Research output: Contribution to journalArticlepeer-review


In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. microRNAs are known to be critical players in the formation of the leukemic phenotype. In this study, we report downregulation of the miR-181a/b gene cluster in APL blasts and NB4 leukemia cells upon ATRA treatment as a key event in the drug response. We found that miR-181a/b expression was activated by the PML/RARa oncogene in cells and transgenic knock-in mice, an observation confirmed and extended by evidence of enhanced expression of miR-181a/b in APL patient specimens. RNA interference (RNAi)-mediated attenuation of miR-181a/b expression in NB4 cells was sufficient to reduce colony-forming capacity, proliferation, and survival. Mechanistic investigations revealed that miR-181a/b targets the ATRA-regulated tumor suppressor gene RASSF1A by direct binding to its 3′-untranslated region. Enforced expression of miR-181a/b or RNAi-mediated attenuation of RASSF1A inhibited ATRA-induced granulocytic differentiation via regulation of the cell-cycle regulator cyclin D1. Conversely, RASSF1A overexpression enhanced apoptosis. Finally, RASSF1A levels were reduced in PML/RARa knock-in mice and APL patient samples. Taken together, our results define miR-181a and miR-181b as oncomiRs in PML/RARa-associated APL, and they reveal RASSF1A as a pivotal element in the granulocytic differentiation program induced by ATRA in APL.

Original languageEnglish
Pages (from-to)3411-3424
Number of pages14
JournalCancer Research
Issue number16
Publication statusPublished - Aug 15 2015

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'PML/RARα-regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in acute promyelocytic leukemia'. Together they form a unique fingerprint.

Cite this